AMPH
Amphastar Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +2.4% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -4 | 22.11M | $440.50M | +3 | −7 |
| Q1 2026 | 84 | -10 | 23.72M | $457.46M | +4 | −14 |
| Q4 2025 | 94 | -1 | 25.83M | $677.54M | — | −1 |
| Q3 2025 | 19 | 0 | 15.63M | $416.60M | — | — |
| Q2 2025 | 16 | +1 | 14.08M | $323.35M | +1 | — |
| Q1 2025 | 12 | -1 | 5.84M | $169.25M | — | −1 |
| Q4 2024 | 13 | 0 | 4.91M | $182.39M | — | — |
| Q3 2024 | 12 | +2 | 3.20M | $155.33M | +2 | — |
| Q2 2024 | 10 | — | 3.67M | $146.92M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.60M | — | $59.26M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 916.08K | -0.5% | $34.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 916.08K | -0.5% | $34.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Marshall Wace ✦ | 608.71K | +7.1% | $22.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 608.71K | +7.1% | $22.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 566.66K | -0.4% | $21.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 566.66K | -0.4% | $21.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 525.50K | +7.4% | $19.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Millennium Management ✦ | 256.56K | -1.2% | $9.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 140.41K | +3.8% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 140.41K | +3.8% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 140.41K | +3.8% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 118.85K | +402.4% | $4.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 118.85K | +402.4% | $4.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 98.18K | -0.6% | $3.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 29.47K | -29.3% | $1.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 29.47K | -29.3% | $1.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 28.45K | -20.4% | $1.06M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 17.78K | -9.8% | $660,319 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 17.78K | -9.8% | $660,319 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Wellington Management ✦ | 17.78K | -9.8% | $660,319 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Wellington Management ✦ | 17.78K | -9.8% | $660,319 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Point72 Asset Management ✦ | 9.20K | -76.3% | $341,596 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 5 tenedores, 1.03M acciones, $928,379 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 7.97K acc. · $161,852
Officer, Director · 8.18K acc. · $183,886
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología